Versatility for your unique testing needs. Experience
flexibility and choice through dynamic MicroScan menu options
designed to streamline testing and help boost your efficiency.
Managechangingformularyneeds
with a broad antimicrobic menu and more than 95 MicroScan panel
choices (available globally)
SelectID-only,AST-only,and ID/ASTcombinationpanelsforworkflow
flexibility
Utilizeaone-panelformatforall Siemens microbiology instruments
for simplified testing procedures and streamlined workflow
Performandinterprettestsmanuallyor on MicroScan
instrumentation
SiemensHealthcareDiagnostics,agloballeaderinclinicaldiagnostics,provideshealthcareprofessionalsinhospital,reference,andphysicianofficelaboratoriesandpoint-of-caresettings
with the vital information required to accurately
diagnose,treat,andmonitorpatients.Ourinnovativeportfolioofperformance-drivensolutionsandpersonalizedcustomercarecombinetostreamlineworkflow,enhanceoperationalefficiency,andsupportimprovedpatient
outcomes.
MicroScan is a trademark of Siemens Healthcare
DiagnosticsInc.
NotavailableforsaleintheU.S.
Productavailabilitymayvaryfromcountrytocountry and is subject to
varying regulatory
requirements.Pleasecontactyourlocalrepresentative for
availability.
OrderNo.A91DX-MM-131323-GC1-4A00 11-2013|Allrightsreserved
2013SiemensHealthcareDiagnosticsInc.
Global Siemens Headquarters SiemensAG Wittelsbacherplatz2
80333Muenchen Germany
Global Siemens Healthcare HeadquartersSiemensAG Healthcare
Sector Henkestrasse127 91052Erlangen Telephone:+49913184-0
Germany
www.siemens.com/healthcare
www.siemens.com/diagnostics
Your First Choice in Resistance Detection MicroScan Gram
Positive Conventional Panels
www.siemens.com/microbiology
Answers for life.
Formorethan30years,MicroScan Systems have been exclusively
focused
onID/ASTtesting,offeringunmatchedexperience,expertise,andtechnicalsupport
to help guide physicians and improve patient care.
MicroScanDriedOvernightGramPositivePanelsfromSiemensnowcontinue a
tradition of quality and innovation.Theyaredesignedtohelpkeep your
laboratory staff at the forefront of identification and
susceptibility testing and are compatible with all MicroScan
instruments. Provideclinicallyrelevant
identification from an extensive databaseofgram-positive
microorganisms
Detectinducibleclindamycinresistance on all Staphylococcus
species(98.7%category agreement to reference method)
EnhanceaccuracyofMRSAdetectionusing integrated cefoxitin screen
(98.7%categoryagreementtoreference method)
Global Division SiemensHealthcareDiagnosticsInc.
511BenedictAvenue Tarrytown,NY10591-5005 USA
www.siemens.com/diagnostics
Aligns with most CLSI guidelines
Stay ahead of emerging resistance the trusted way.
First-time accuracy
TheMicroScansystemusesagrowth-based,non-ID-dependentdirecttestingmethod,whichallowsforbetterdetectionofemergingresistance.Thesystemdoesnotrelyonhistoricaldata:Itprovidesareal-timeadvantageforaccuracyandusesdirectMIC*
technology to detect
emergingandlow-levelresistance.Thismeansfewerconfirmatory
testsareneeded,providingyouwithaccurateresultsthefirsttime.
ThisfunctionalityalignswithmostCLSIguidelinestoimprovedetection of
resistance mechanisms without additional confirmation tests.
*Minimum inhibitory concentration
Panel Name Pos Combo 31 Pos Combo 32 Pos Combo 39 Pos Combo 41
Pos Combo 42 Pos BP Combo 28 Pos BP Combo 29 Pos MIC 28 Pos MIC
33
SMN 10371521 10371522 10701096 10713827 10713829 10371520
10371527 10371528 10713828
Legacy Catalog Number B1016139 B1016 140 B1016 167 B1016 172
B1016 174 B1016 138 B1016 145 B1016 146 B1016 173
Languages E,ES,GR,PL,PT,TR E,ES,GR,PL,PT,TR DE,E,ES,FR,IT,KO,PT
DE,E,ES,FR,IT,PTDE,E,ES,FR,GR,
IT,PL,PT,TRDE,E,ES,FR,GR,IT,PL,PT,TR
E,IT,DE,ES,GR,PL,TRDE,E,ES,GR,IT,KO,PL,PT,TR
DE,E,ES,FR,GR,IT,PL,PT,TR
Abbr. Antimicrobic Agent g/mL g/mL g/mL g/mL g/mL g/mL g/mL g/mL
g/mL Abbr.Ak Amikacin 832 1632 832 AkAug Amoxicillin/KClavulanate
4/2 4/2 4/2 4/28/4 4/28/4 4/2 4/216/8 4/28/4 AugAm Ampicillin 18 28
0.25,48 0.25,48 0.25,8 0.258 0.25,48 AmA/S Ampicillin/Sulbactam
8/416/8 8/416/8 A/SAbk Arbekacin 48 AbkAzi Azithromycin 24 24 24
AziCfz Cefazolin 816 CfzCpe Cefepime 416 CpeCfxS CefoxitinScreen 4
4 4 4 4 4 4 4 4 CfxSCpt Ceftaroline 0.51 0.51 CptCax Ceftriaxone
8,32 CaxCrm Cefuroxime 416 416 CrmCf Cephalothin 816 816 CfC
Chloramphenicol 816 816 CCp Ciprofloxacin 12 0.52 12 12 12 12 12
0.52 12 CpCla Clarithromycin 24 24 ClaCd Clindamycin 0.252 0.252
0.250.5,2 0.250.5,24 0.252 0.250.5,2 0.250.5,2 0.250.5,2 0.252
CdDap Daptomycin 14 0.54 1,4 0.54 14 14 1,4 14 14 DapEtp Ertapenem
0.54 EtpE Erythromycin 0.54 0.254 0.54 0.54 0.54 0.54 0.5,4 0.54
0.54 E
Fos Fosfomycin 3264 3264 3264 32 32 32 3264 FosFA FusidicAcid
2,16 2,16 2,16 2,16 2,16 2 FAGm Gentamicin 1,48 1,48 48 18 1,48
1,48 48 48 18 GmGmS GentamicinSynergyScreen 500 500 500 500 500 500
500 500 GmSImp Imipenem 48 28 48 ImpICd InducibleClindamycinTest
4/0.5 4/0.5 4/0.5 4/0.5 4/0.5 4/0.5 4/0.5 4/0.5 4/0.5 ICdLvx
Levofloxacin 14 14 14 14 14 14 14 14 14 LvxLzd Linezolid 24 14 14
24 24 24 24 14 14 LzdMer Meropenem 2 8 MerMin Minocycline 18 MinMxf
Moxifloxacin 0.51 0.51 0.51 0.51 MxfMup Mupirocin 48,256 48,256 256
48,256 48,256 256 MupNt Netilmicin 816 NtFd Nitrofurantoin 3264
3264 3264 3264 3264 3264 3264 3264 3264 Fd
Nxn Norfloxacin 48 48 NxnOx Oxacillin 0.252 0.252 0.25,12 0.252
0.252 0.25,12 0.25,12 0.252 0.252 OxP Penicillin 0.03,0.120.25
0.03,0.120.25,2,8 0.03,0.120.25,2,8 0.120.25,2,8 0.120.25
0.03,0.12,8 0.030.12,8 0.030.12,2,8 0.120.25,8 PPrs Pristinamycin
12 12 PrsRif Rifampin 0.52 12 12 12 12 0.52 RifStS Streptomycin
Synergy Screen 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000
StSSyn Synercid 0.52 0.52 14 12 12 12 14 SynTei Teicoplanin 116 116
816 216 216 416 116 116 116 TeiTe Tetracycline 1,48 18 48 28 18 48
28 48 18 TeTo Tobramycin 1,48 1,48 48 18 ToT/S
Trimethoprim/Sulfamethoxazole 1/194/76 1/194/76 0.5/9.5,2/38
2/384/76 2/384/76 2/38 2/384/76 2/384/76 T/SVa Vancomycin 0.516 116
0.2516 0.2516 116 0.516 0.516 0.516 0.2516 Va
Total Antimicrobics/Panel 23 21 28 24 26 28 30 33 34
Panel DefinitionsPosCombo:Provides gram-positiveidentification
and susceptibility results ononepanel.Drugselectionprovides both
staphylococci andenterococcicoverage, as well as urine and systemic
reporting.PosBPCombo:Provides gram-positiveidentification and
susceptibility results on onepanel.Drugselectionprovides both
staphylococci andenterococcicoverage, as well as urine and systemic
reporting.Panelcontainsshorter dilutions around the
breakpoints,allowingfor a broader drug
menu.PosMIC:Providegram-positivesusceptibility results only and
longer dilution schemes for better detection of emerging
resistance.Drugselectionprovides both staphylococci and
enterococcicoverage,aswell as urine and systemic reporting.
Legend: DEGerman E English ES Spanish FRFrench GRGreek ITItalian
KOKorean PLPolish PTPortuguese TRTurkish
